Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul J. Utz is active.

Publication


Featured researches published by Paul J. Utz.


Proceedings of the National Academy of Sciences of the United States of America | 2003

Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors

Robert Chen; Sarunya Bangsaruntip; Katerina A. Drouvalakis; Nadine Wong Shi Kam; Moonsub Shim; Yiming Li; Woong Kim; Paul J. Utz; Hongjie Dai

Novel nanomaterials for bioassay applications represent a rapidly progressing field of nanotechnology and nanobiotechnology. Here, we present an exploration of single-walled carbon nanotubes as a platform for investigating surface–protein and protein–protein binding and developing highly specific electronic biomolecule detectors. Nonspecific binding on nanotubes, a phenomenon found with a wide range of proteins, is overcome by immobilization of polyethylene oxide chains. A general approach is then advanced to enable the selective recognition and binding of target proteins by conjugation of their specific receptors to polyethylene oxide-functionalized nanotubes. This scheme, combined with the sensitivity of nanotube electronic devices, enables highly specific electronic sensors for detecting clinically important biomolecules such as antibodies associated with human autoimmune diseases.


Nature Medicine | 2002

Autoantigen microarrays for multiplex characterization of autoantibody responses

William H. Robinson; Carla Digennaro; Wolfgang Hueber; Brian B. Haab; Makoto Kamachi; Erik J. Dean; Sylvie Fournel; Derek A. Fong; Karl Skriner; David L. Hirschberg; Robert I. Morris; Sylviane Muller; Ger J. M. Pruijn; Josef S Smolen; Patrick O. Brown; Lawrence Steinman; Paul J. Utz

We constructed miniaturized autoantigen arrays to perform large-scale multiplex characterization of autoantibody responses directed against structurally diverse autoantigens, using submicroliter quantities of clinical samples. Autoantigen microarrays were produced by attaching hundreds of proteins, peptides and other biomolecules to the surface of derivatized glass slides using a robotic arrayer. Arrays were incubated with patient serum, and spectrally resolvable fluorescent labels were used to detect autoantibody binding to specific autoantigens on the array. We describe and characterize arrays containing the major autoantigens in eight distinct human autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. This represents the first report of application of such technology to multiple human disease sera, and will enable validated detection of antibodies recognizing autoantigens including proteins, peptides, enzyme complexes, ribonucleoprotein complexes, DNA and post-translationally modified antigens. Autoantigen microarrays represent a powerful tool to study the specificity and pathogenesis of autoantibody responses, and to identify and define relevant autoantigens in human autoimmune diseases.


Cancer Research | 2012

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Seng Ryong Woo; Meghan E. Turnis; Monica V. Goldberg; Jaishree Bankoti; Mark J. Selby; Christopher Nirschl; Matthew L. Bettini; David M. Gravano; Peter Vogel; Chih Long Liu; Stephanie Tangsombatvisit; Joseph F. Grosso; George J. Netto; Matthew P. Smeltzer; Alcides Chaux; Paul J. Utz; Creg J. Workman; Drew M. Pardoll; Alan J. Korman; Charles G. Drake; Dario A. A. Vignali

Inhibitory receptors on immune cells are pivotal regulators of immune escape in cancer. Among these inhibitory receptors, CTLA-4 (targeted clinically by ipilimumab) serves as a dominant off-switch while other receptors such as PD-1 and LAG-3 seem to serve more subtle rheostat functions. However, the extent of synergy and cooperative interactions between inhibitory pathways in cancer remain largely unexplored. Here, we reveal extensive coexpression of PD-1 and LAG-3 on tumor-infiltrating CD4(+) and CD8(+) T cells in three distinct transplantable tumors. Dual anti-LAG-3/anti-PD-1 antibody treatment cured most mice of established tumors that were largely resistant to single antibody treatment. Despite minimal immunopathologic sequelae in PD-1 and LAG-3 single knockout mice, dual knockout mice abrogated self-tolerance with resultant autoimmune infiltrates in multiple organs, leading to eventual lethality. However, Lag3(-/-)Pdcd1(-/-) mice showed markedly increased survival from and clearance of multiple transplantable tumors. Together, these results define a strong synergy between the PD-1 and LAG-3 inhibitory pathways in tolerance to both self and tumor antigens. In addition, they argue strongly that dual blockade of these molecules represents a promising combinatorial strategy for cancer.


Nature | 2007

RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination

Adam G. W. Matthews; Alex J. Kuo; Santiago Ramón-Maiques; Sunmi Han; Karen S. Champagne; Dmitri Ivanov; Mercedes Gallardo; Dylan Carney; Peggie Cheung; David N. Ciccone; Kay L. Walter; Paul J. Utz; Yang Shi; Tatiana G. Kutateladze; Wei Yang; Or Gozani; Marjorie A. Oettinger

Nuclear processes such as transcription, DNA replication and recombination are dynamically regulated by chromatin structure. Eukaryotic transcription is known to be regulated by chromatin-associated proteins containing conserved protein domains that specifically recognize distinct covalent post-translational modifications on histones. However, it has been unclear whether similar mechanisms are involved in mammalian DNA recombination. Here we show that RAG2—an essential component of the RAG1/2 V(D)J recombinase, which mediates antigen-receptor gene assembly—contains a plant homeodomain (PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 (H3K4me3). The high-resolution crystal structure of the mouse RAG2 PHD finger bound to H3K4me3 reveals the molecular basis of H3K4me3-recognition by RAG2. Mutations that abrogate RAG2’s recognition of H3K4me3 severely impair V(D)J recombination in vivo. Reducing the level of H3K4me3 similarly leads to a decrease in V(D)J recombination in vivo. Notably, a conserved tryptophan residue (W453) that constitutes a key structural component of the K4me3-binding surface and is essential for RAG2’s recognition of H3K4me3 is mutated in patients with immunodeficiency syndromes. Together, our results identify a new function for histone methylation in mammalian DNA recombination. Furthermore, our results provide the first evidence indicating that disrupting the read-out of histone modifications can cause an inherited human disease.


Nature Biotechnology | 2008

Protein microarrays with carbon nanotubes as multicolor Raman labels

Zhuo Chen; Scott M. Tabakman; Andrew P. Goodwin; Michael G. Kattah; Dan Daranciang; Xinran Wang; Guangyu Zhang; Xiaolin Li; Zhuang Liu; Paul J. Utz; Kaili Jiang; Shoushan Fan; Hongjie Dai

The current sensitivity of standard fluorescence-based protein detection limits the use of protein arrays in research and clinical diagnosis. Here, we use functionalized, macromolecular single-walled carbon nanotubes (SWNTs) as multicolor Raman labels for highly sensitive, multiplexed protein detection in an arrayed format. Unlike fluorescence methods, Raman detection benefits from the sharp scattering peaks of SWNTs with minimal background interference, affording a high signal-to-noise ratio needed for ultra-sensitive detection. When combined with surface-enhanced Raman scattering substrates, the strong Raman intensity of SWNT tags affords protein detection sensitivity in sandwich assays down to 1 fM—a three-order-of-magnitude improvement over most reports of fluorescence-based detection. We use SWNT Raman tags to detect human autoantibodies against proteinase 3, a biomarker for the autoimmune disease Wegeners granulomatosis, diluted up to 107-fold in 1% human serum. SWNT Raman tags are not subject to photobleaching or quenching. By conjugating different antibodies to pure 12C and 13C SWNT isotopes, we demonstrate multiplexed two-color SWNT Raman-based protein detection.


Journal of Biological Chemistry | 2007

Proteome-wide Analysis in Saccharomyces cerevisiae Identifies Several PHD Fingers as Novel Direct and Selective Binding Modules of Histone H3 Methylated at Either Lysine 4 or Lysine 36

Xiaobing Shi; Ioulia Kachirskaia; Kay L. Walter; Jen Hao A. Kuo; Aimee Lake; Foteini Davrazou; Steve M. Chan; David G.E. Martin; Ian M. Fingerman; Scott D. Briggs; LeAnn Howe; Paul J. Utz; Tatiana G. Kutateladze; Alexey A. Lugovskoy; Mark T. Bedford; Or Gozani

The PHD finger motif is a signature chromatin-associated motif that is found throughout eukaryotic proteomes. Here we have determined the histone methyl-lysine binding activity of the PHD fingers present within the Saccharomyces cerevisiae proteome. We provide evidence on the genomic scale that PHD fingers constitute a general class of effector modules for histone H3 trimethylated at lysine 4 (H3K4me3) and histone H3 trimethylated at lysine 36 (H3K36me3). Structural modeling of PHD fingers demonstrates a conserved mechanism for recognizing the trimethyl moiety and provides insight into the molecular basis of affinity for the different methyl-histone ligands. Together, our study suggests that a common function for PHD fingers is to transduce methyl-lysine events and sheds light on how a single histone modification can be linked to multiple biological outcomes.


Journal of Clinical Investigation | 2006

Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis

Ricardo T. Paniagua; Orr Sharpe; Peggy P. Ho; Steven M. Chan; Anna Chang; John P. Higgins; Beren Tomooka; Fiona M. Thomas; Jason Jungsik Song; Stuart B. Goodman; David M. Lee; Mark C. Genovese; Paul J. Utz; Lawrence Steinman; William H. Robinson

Tyrosine kinases play a central role in the activation of signal transduction pathways and cellular responses that mediate the pathogenesis of rheumatoid arthritis. Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor developed to treat Bcr/Abl-expressing leukemias and subsequently found to treat c-Kit-expressing gastrointestinal stromal tumors. We demonstrate that imatinib potently prevents and treats murine collagen-induced arthritis (CIA). We further show that micromolar concentrations of imatinib abrogate multiple signal transduction pathways implicated in RA pathogenesis, including mast cell c-Kit signaling and TNF-alpha release, macrophage c-Fms activation and cytokine production, and fibroblast PDGFR signaling and proliferation. In our studies, imatinib attenuated PDGFR signaling in fibroblast-like synoviocytes (FLSs) and TNF-alpha production in synovial fluid mononuclear cells (SFMCs) derived from human RA patients. Imatinib-mediated inhibition of a spectrum of signal transduction pathways and the downstream pathogenic cellular responses may provide a powerful approach to treat RA and other inflammatory diseases.


Nature Medicine | 2004

Protein microarrays for multiplex analysis of signal transduction pathways

Steven M. Chan; Joerg Ermann; Leon Su; C. Garrison Fathman; Paul J. Utz

We have developed a multiplexed reverse phase protein (RPP) microarray platform for simultaneous monitoring of site-specific phosphorylation of numerous signaling proteins using nanogram amounts of lysates derived from stimulated living cells. We first show the application of RPP microarrays to the study of signaling kinetics and pathway delineation in Jurkat T lymphocytes. RPP microarrays were used to profile the phosphorylation state of 62 signaling components in Jurkat T cells stimulated through their membrane CD3 and CD28 receptors, identifying a previously unrecognized link between CD3 crosslinking and dephosphorylation of Raf-1 at Ser259. Finally, the potential of this technology to analyze rare primary cell populations is shown in a study of differential STAT protein phosphorylation in interleukin (IL)-2-stimulated CD4+CD25+ regulatory T cells. RPP microarrays, prepared using simple procedures and standard microarray equipment, represent a powerful new tool for the study of signal transduction in both health and disease.


Arthritis & Rheumatism | 1998

Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens

Paul J. Utz; Paul Anderson

The role of apoptosis or programmed cell death in the pathophysiology of rheumatic diseases hab been an active area of research, and advances in the field were reviewed in a recent issue of Arthritis & Rlieurrintisrn (I). Defect5 in the regulation of apoptosis have been observed in both hematopoietic and nonhematopoietic tissues derived from patients with systemic lupus erythematosus (SLE), a dibcase characterized by immune abnormalities that allow the production of antinuclear antibodies directed against self antigens, particularly RNP complexes (23). In this review, we discuss the role of cell death in the generation of autoantibodies in patients with SLE and scleroderma, and wc present a unifying hypothesis to explain how defective apoptosis or ineffectivc clearance of apoptotic cells and modified autoantigens might contribute to the bypass of tolerance that is required for autoantibody formation.


Immunity | 2010

The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity

Rita M. Tavares; Emre E. Turer; Chih L. Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A. Lowell; Paul J. Utz; Barbara A. Malynn; Averil Ma

A20 is a ubiquitin modifying enzyme that restricts NF-kappaB signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20s roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-kappaB responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-kappaB-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.

Collaboration


Dive into the Paul J. Utz's collaboration.

Researchain Logo
Decentralizing Knowledge